Epstein-Barr Virus-Associated Non-Hodgkin's Lymphoma in HIV-infected Patients

References

• Moore R. D., Kessler H., Richman D. D., Flexner C., Chaisson R. E. Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with Zidovudine. JAMA 1990; 265: 2208–2211
   Web of Science ®Google Scholar
• Gail M. H., Pluda J. M., Rabkin C. S., Biggar R. J., Goedert J. J., Horm J. W., Sondik E. J., Yarchoan R., Broder S. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J. Natl. Cancer Inst. 1991; 83: 695–701
   PubMed Web of Science ®Google Scholar
• Levine A. M. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992; 80: 8–20
   PubMed Web of Science ®Google Scholar
• Knowles D. M., Chamulak G. A., Subar M., Burke J. S., Dugan M., Wemz J., Slywotzky C., Pelicci P.-G., Della-Favera R., Raphael B. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (ADDS): The New York University Medical Center Experience with 105 patients (1981–1986). Ann. Intern. Med. 1988; 108: 744–753
   PubMed Web of Science ®Google Scholar
• Ballerini P., Gaidano G., Gong J. Z., Tassi V., Saglio G., Knowles D. M., Dalla-Favera R. Multiple genetic lesions in acquired immonodefiency syndrome-related non-Hodgkin's lymphoma. Blood 1993; 81: 166–176
   PubMed Web of Science ®Google Scholar
• Nakamura H., Said J. W., Miller C. W., Koeffler H. P. Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas. Blood 1993; 82: 920–926
   PubMed Web of Science ®Google Scholar
• Subar M., Neri A., Inghirami G., Knowles D. M., Dalla-Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in ATDS-associated lymphoma. Blood 1988; 72: 667–671
   PubMed Web of Science ®Google Scholar
• Shibata D., Weiss L. M., Hernandez A. M., Nathwani B. N., Bernstein L., Levine A. M. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 1993; 81: 2102–2109
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton-Dutoit S. J., Rowe M., Lisse I., Ralfkiaer E., Sandveu K., Young L. S. Expression of Epstein-Barr Virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. J. Pathol. 1991; 165: 289–299
   PubMed Web of Science ®Google Scholar
• Ernberg I., Altiok E. The role of Epstein-Barr virus in lymphomas of HIV-carriers. APMIS 1989; Suppl. 8: 58–61
   Google Scholar
• Boyle M. J., Sewell W. A., Sculley T. B., Apolloni A., Turner J. J., Swanson C. E., Penny R., Cooper D. A. Subtypes of Epstein-Barr vims in human immunodeficiency virus-associated non-Hodgkin's lymphoma. Blood 1991; 78: 3004–3011
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S. J., Pallesen G., Franzmann M. B., Karkov J., Black F., Skinhoj P., Pedersen C. AIDS-related lymphoma. Am. J. Pathol. 1991; 138: 149–163
   PubMed Web of Science ®Google Scholar
• Pedersen C., Gerstoft J., Lundgren J. D., Skinhoj P., Bot-Tzauw J., Geisler C., Hamilton-Dutoit S. J., Thorsen S., Lisse I., Ralfkiaer E., Pallesen G. HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur. J. Cancer 1991; 27: 1416–1423
   PubMed Web of Science ®Google Scholar
• Guarner J., del Rio C., Carr D., Hendrix L. E., Eley J. W., Unger E. R. Non-Hodgkin's lymphomas in patients with human immunodeficiency virus infection. Cancer 1991; 68: 2460–2465
   PubMed Web of Science ®Google Scholar
• MacMahon E. M., Glass J. D., Hayward S. D., Mann R. B., Becker P. S., Charache P., McArthur J. C., Am-Binder R. F. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991; 338: 969–973
   PubMed Web of Science ®Google Scholar
• Levine A. M., Sullivan-Halley J., Picke M. C., Rarick M. U., Loureiro C., Bernstein-Singer M., Wilson E., Brynes R., Parker J., Rasheed S., Gill P. S. HIV-related lymphoma: prognostic factors predictive of survival. Cancer 1991; 68: 2466–2472
   PubMed Web of Science ®Google Scholar
• Raab-Traub N., Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47: 883–889
   PubMed Web of Science ®Google Scholar
• Rocchi G., DeFelici A., Heinz A. Quantitative evaluation of EBV infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N. Engl. J. Med. 1977; 293: 132–134
   Web of Science ®Google Scholar
• Baer B., Bankier A., Biggen M., et al. DNA sequence expression of the B95–8 Epstein-Barr virus genome. Nature 1984; 310: 207–211
   PubMed Web of Science ®Google Scholar
• Rickinson A. B., Young L. S., Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus transformed B cells. J. Virol. 1987; 61: 1310–1317
   PubMed Web of Science ®Google Scholar
• Yates Warren J. N., Sugden D., Reisman B. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 1984; 81: 3806–3810
   PubMed Web of Science ®Google Scholar
• Rowe M., Rowe D. T., Gregory C. D., Young L. S., Farrell P. J., Rupani H., Rickerson A. B. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma. EMBO 1987; 6: 2743–2751
   PubMed Web of Science ®Google Scholar
• Gregory C. D., Rowe M., Rickerson A. B. Different Epstein-Barr virus (EBV) B cell interactions in phenotypically distinct clones of a Burkitt lymphoma cell line. J. Gen. Virol. 1990; 71: 1481–1495
   PubMed Web of Science ®Google Scholar
• Howe J. G., Steitz J. A. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc. Natl. Acad. Sci. USA 1991; 83: 9006–9010
   Web of Science ®Google Scholar
• Neri A., Barriga F., Inghirami G., Knowles D. M., Nee-Quaye J., Magrath I. T., Dalla-Favera R. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 1991; 77: 1092–1095
   PubMed Web of Science ®Google Scholar
• Epstein M. A., Achong B. G. The relationship of the Epstein Barr Virus to Burkitt's lymphoma. The Epstein-Barr Virus, M. A. Epstein, B. G. Achong. Springer-Verlag, New York, NY 1979; 321–337
   Google Scholar
• Magrath I. The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 1990; 55: 133–270
   PubMedGoogle Scholar
• Shiramizu B., Barriga F., Neequage J., Jafri A., Dalla-Favera R., Neri A., Guttierez M., Levine P., Magrath I. Patterns of chromosomal breakpoint locations in Burkitt's Lymphoma: Relevance to geography and Epstein-Barr Virus Association. Blood 1991; 77: 1516–1526
   PubMed Web of Science ®Google Scholar
• Pelicci P. G., Knowles D. M., Magrath I., Dalla-Favera R. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt's lymphoma. Proc. Natl. Acad. Sci. USA 1986; 83: 2984–2988
   PubMed Web of Science ®Google Scholar
• Neri A., Barriga F., Knowles D. M., Magrath I. T., Dalla-Favera R. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc. Natl. Acad. Sci. USA 1988; 85: 2748–2752
   PubMed Web of Science ®Google Scholar
• Gutierrez M., Bhatia K., Barriga F., Diez B., Sackmann M. F., de Andreas M. L., Epelman S., Risueno C., Magrath I. T. Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood 1992; 79: 3261–3266
   PubMed Web of Science ®Google Scholar
• Penn I. Principles of tumor immunity: Immunocompromised patients. AIDS Updates 1990; 3: 1
   Google Scholar
• Frizzera G., Rosai J., Dehner L. P., Spector B. A., Kersey J. H. Lymphoreticular disorders in primary immunodeficiency: New findings based on an updated histological classification of 35 cases. Cancer 1980; 46: 692–699
   PubMed Web of Science ®Google Scholar
• Grierson H., Purtilo D. T. Epstein Barr virus infection in males with the X-linked lymphoproliferative syndrome. Ann. Intern. Med. 1987; 106: 538–545
   PubMed Web of Science ®Google Scholar
• Hanto D. W., Gajl-Peczalska K. J., Frizzera G., Authur D. C., Balfour H. H., McClain K., Simmons R. L., Najarian J. S. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Ann. Surg. 1983; 198: 356–369
   PubMed Web of Science ®Google Scholar
• Hanto D. W., Birkenbach M., Fizzera G., Gajl-Peczalska K. J., Simmons R. L., Schubach W. H. Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B-cell proliferations by immunoglobulin gene rearrangement analysis. Transplantation 1989; 47: 458–464
   PubMed Web of Science ®Google Scholar
• Hanto W. D., Grizzera G., Gajl-Peczalska K. J., Simmons R. L. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985; 39: 461–472
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Dorfman R. F., Sklar J. Failure in immunological control of the virus infection: post-transplant lymphomas. The Epstein-Barr Virus, M. A. Epstein, B. G. Achong. John Wiley & Sons, New York, NY 1986; 164–181
   Google Scholar
• Cleary M. L., Sklar J. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 1984; 2: 489–493
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Nalesnik M. A., Shearer W. T., Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988; 72: 349–352
   PubMed Web of Science ®Google Scholar
• Shiramizu B., Herndier B., Meeker T., Kaplan L., McGrath M. Molecular and immunophenotypic characterization of AIDS-associated, Epstein-Barr virus-negative, polyclonal lymphoma. J. Clin. Oncol. 1992; 10: 383–389
   PubMed Web of Science ®Google Scholar
• Haluska F. G., Russo G., Kant J., Andreef M., Croce C. M. Molecular resemblance of an AIDS-associated lymphoma and endemic Burkitt lymphomas: implications for their pathogenesis. Proc. Natl. Acad. Sci. USA 1989; 86: 8907–8911
   PubMed Web of Science ®Google Scholar
• Rowe M., Lear A. L., Groom-Carter D., Davies A. H., Rickinson A. B. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J. Virol. 1992; 66: 122–131
   PubMed Web of Science ®Google Scholar
• Schaefer B. C., Woisetschlaeger M., Strominger J. L., Speck S. H. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc. Natl. Acad. Sci. USA 1991; 88: 6550–6554
   PubMed Web of Science ®Google Scholar
• Sample J., Brooks L., Sample C., Young L., Rowe M., Gregory C., Rickinson A., Kieff E. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcription initiation site. Proc. Natl. Acad. Sci. USA 1991; 88: 6343–6347
   PubMed Web of Science ®Google Scholar
• Young L., Alfieri C., Hennessy K., Evans H., O'Hara C., Anderson C., Rigz J., Shapiro R. S., Rickinson A., Kieff E., Cohen J. I. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 1989; 321: 1080–1085
   PubMed Web of Science ®Google Scholar
• Herbst H., Dallenbach F., Hummel M., Niedobitek G., Pileri S., Muller-Lantzsch N., Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad. Sci. USA 1991; 88: 4766–4770
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 1991; 337: 320–322
   PubMed Web of Science ®Google Scholar
• Brooks L., Yao Q. Y., Rickinson A. B., Young L. S. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol. 1992; 66: 2689–2697
   PubMed Web of Science ®Google Scholar
• Deacon E. M., Pallesen G., Niedobitek G., Crocker J., Brooks L., Rickinson A. B., Young L. S. Epstein-Barr virus and Hodgkin's Disease: Transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 1993; 177: 339–349
   PubMed Web of Science ®Google Scholar
• Murray R. J., Wang D., Young L. S., Wang F., Rowe M., Kieff E., Rickinson A. B. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. J. Virol. 1988; 62: 3747–3755
   PubMed Web of Science ®Google Scholar
• Murray R. J., Kurilla M. G., Brooks J. M., Thomas W. A., Rowe M., Kieff E., Rickinson A. B. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 1992; 176: 157–168
   PubMed Web of Science ®Google Scholar
• Wang D., Liebowitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831–840
   PubMed Web of Science ®Google Scholar
• Whittle H. C., Brown J., Marsh K., Greenwood B. M., Seidelin P., Tighe H., Wedderburn L. T-cell control of Epstein-Barr virus-infected B-cells is lost during P. falciparum malaria. Nature 1984; 312: 449–450
   PubMed Web of Science ®Google Scholar
• O'Conner G. T. Persistent immunological stimulation as a factor in oncogenesis with special reference to Burkitt's tumor. Am. J. Med. 1970; 48: 279–285
   PubMed Web of Science ®Google Scholar
• Goldschmidts W. L., Bhatia K., Johnson J. F., Akar N., Gutierrez M. I., Shibata D., Carolan M., Levine A., Magrath I. T. Epstein-Barr Virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas. Leukemia 1992; 6: 875–878
   PubMed Web of Science ®Google Scholar
• Young L. S., Yao Q. Y., Rooney C. M., Sculley T. B., Moss D. J., Rupiani H., Laux G., Bornkamm G. W., Rickinson A. B. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J. Gen. Virol. 1987; 68: 2853–2862
   PubMed Web of Science ®Google Scholar
• Pelicci P.-G., Knowles D. M., Arlin Z. A., Wieczorek R., Luciw P., Dina D., Basilico C., Dalla-Favera R. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. J. Exp. Med. 1986; 164: 2049–2060
   PubMed Web of Science ®Google Scholar
• Arber D. A., Shibata D., Chen Y. Y., Weiss L. M. Characterization of the topography of Epstein-Barr virus infection in human immunodeficiency virus associated lymphoid tissues. Mod. Pathol. 1992; 5: 559–566
   PubMed Web of Science ®Google Scholar
• Birx D. L., Redfield R. R., Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N. Engl. J. Med. 1986; 314: 874–879
   PubMed Web of Science ®Google Scholar
• Shibata D., Weiss L. M., Nathwani B. N., Brynes R. K., Levine A. M. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with the concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 1991; 77: 1527–1533
   PubMed Web of Science ®Google Scholar